Aytac, P. Et Al. 2022. Design, Synthesis and Biological Evaluation of Novel Triazolothiadiazoles Derived from NSAIDs as Anticancer Agents. ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY , vol.22, no.7 , 1340-1347.

Aytac, P., Sahin, I. D., ATALAY, R., & TOZKOPARAN KÖPRÜCÜ, B., (2022). Design, Synthesis and Biological Evaluation of Novel Triazolothiadiazoles Derived from NSAIDs as Anticancer Agents. ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY , vol.22, no.7, 1340-1347.

Aytac, Peri Et Al. "Design, Synthesis and Biological Evaluation of Novel Triazolothiadiazoles Derived from NSAIDs as Anticancer Agents," ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY , vol.22, no.7, 1340-1347, 2022

Aytac, Peri Et Al. "Design, Synthesis and Biological Evaluation of Novel Triazolothiadiazoles Derived from NSAIDs as Anticancer Agents." ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY , vol.22, no.7, pp.1340-1347, 2022

Aytac, P. Et Al. (2022) . "Design, Synthesis and Biological Evaluation of Novel Triazolothiadiazoles Derived from NSAIDs as Anticancer Agents." ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY , vol.22, no.7, pp.1340-1347.

@article{article, author={Peri Aytac Et Al. }, title={Design, Synthesis and Biological Evaluation of Novel Triazolothiadiazoles Derived from NSAIDs as Anticancer Agents}, journal={ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY}, year=2022, pages={1340-1347} }